Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 68 for “"Systemic chemotherapy"”.
-
Development and Optimization of Polymeric Carriers for Lymphatic Imaging and Drug Delivery
… drops to less than 20%. However, conventional systemic chemotherapy offers limited penetration into the lymphatic to treat lymphatic metastases, and often the dose limiting toxicities associated with systemic chemotherapy limit the dose to below that needed for effective treatment. Therefore, …
-
Enhancing the neoadjuvant treatment of rectal cancer by targeting the Inhibitor of Apoptosis Proteins
… rectal cancer, combining (chemo)radiation and systemic chemotherapy prior to surgery. This strategy improves tumour downstaging, increasing the likelihood of non-operative management, and reduces local and distant recurrence. However, most patients still require major surgery, and approximately …
-
Tissue Engineering, Regenerative Medicine, and Clinical Applications in Orthopedics: From Bench to Bedside
… voids. In addition, patients with OS undergo systemic chemotherapy to prevent micro-metastases and recurrence. However, treatment is suboptimal; allografts are obtained from tissue banks and need to be matched for major histocompatibility complexes, limiting availability, and though prosthetic …
-
Deep learning for residual disease stratification in early breast cancer
… process for administering neoadjuvant systemic chemotherapy (NAC) still poses significant challenges. This research aims to improve the characterisation of residual disease (RD) in surgical specimens of breast cancer patients following NAC. Utilising a deep learning approach to analyse …
-
A cost-utility analysis of liver resection for malignant tumours: a pilot project
… resection, radiofrequency ablation (RFA), systemic chemotherapy, and symptom control only for the treatment of colorectal liver metastases. Seven patients underwent hepatic resection, 7 underwent RFA, 20 received chemotherapy, and 6 received symptom control alone. Liver resection provided …
-
Treatment at Disease-progression in EGFR-mutated NSCLC Patients: Results from a single Canadian Institution
… Compared to the GLD-NSCLC cohort without systemic chemotherapy, EGFRmut+ patients were more likely to be younger, female and Asian. Further, continuing TKI treatment beyond PD was associated with improved OS and PPS vs. discontinuation of TKI. A non-independent relationship between …
-
Η περιοχική ενδαρτηριακή χημειοθεραπεία του προχωρημένου καρκίνου της ουροδόχου κύστης
… It has the following advances: 1) it has not systemic adverse effects, 2) it can be applied to elderly people, 3) it delivers high concentrations of the applied drug into the tumor tissue, 4) it preserves the urinary bladder and 5) it is favored by the anatomical position of the urinary …
-
Do Negative Expectations Affect Self-Reported Cognitive Functioning and Treatment Satisfaction after Chemotherapy Treatment for Cancer?
… and endorsement of a common, negative chemotherapy-related stereotype in 56 adults who had completed systemic chemotherapy for cancer treatment. Participants were assigned to either a negative expectation group or a control group. The negative expectation group had the relationship …
-
Do Negative Expectations Affect Self-Reported Cognitive Functioning and Treatment Satisfaction after Chemotherapy Treatment for Cancer?
… and endorsement of a common, negative chemotherapy-related stereotype in 56 adults who had completed systemic chemotherapy for cancer treatment. Participants were assigned to either a negative expectation group or a control group. The negative expectation group had the relationship …
-
Giant cell carcinoma of the endometrium: a case report of a rare entity and review of the literature /
… management, followed by multiple lines of systemic chemotherapy. The disease progressed rapidly, and she died 12 months after diagnosis. The literature review shows heterogeneity in clinical presentation, therapeutic approaches, and patient outcomes. Notably, the aggressive course observed …
-
Electrolytic Microsystems for Biomedical applications
… inoperable tumors in the liver and brain. Systemic chemotherapy has side effects and radiation is expensive. Challenges of current technologies for treating the liver include poor performance near vascular structures and the inability to treat multiple nodular tumors. Brain tumor treatment …
-
Multimodal Treatment and Neoadjuvant Chemotherapy Trends, Utilization and Survival Effects in Intrahepatic Cholangiocarcinoma – a Propensity Score Analysis
… surgery (CIS). In this context, additional systemic chemotherapy (multimodal treatment) is recommended for most patients but reported survival benefits are minimal and are limited to small single institutional studies. For this reason, using a national cancer registry, we sought to …
-
Combined modality management of peritoneal metastases with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
… Survival with palliative management including systemic chemotherapy and best supportive care rarely exceeds 12 months. With advances in surgical technology and multi-modality therapy, a combined approach of surgery and chemotherapy was introduced. This surgical technique termed peritonectomy …
-
Trends and Comparative Effectiveness in Treatment of Stage IV Colorectal Adenocarcinoma
… evolving. Primary treatment modalities include systemic chemotherapy, resection of the primary tumor, and, in select cases, resection of metastatic disease. Historically, stage IV disease was first managed with surgical resection to prevent complications such as obstruction, bleeding, and …
-
CYTOTOXICITY OF Se-LABELED ANTIBODIES AND SELENOFOLATE AGAINST TRIPLE NEGATIVE BREAST CANCER CELL LINES MDA-MB-231 AND MDA-MB-468
… essential for “targeted therapies” of BC. Thus, systemic chemotherapy is the only TNBC drug treatment option for these patients. In this study, Folate or two clinical monoclonal antibodies; Herceptin® or Avastin® were covalently labeled with redox selenium and used to treat two TNBC cell lines …
-
Liposomal encapsulation of irinotecan and potential for the use of liposomal drug in the treatment of liver metastases associated with advanced colorectal cancer
… which are relatively unresponsive to the systemic chemotherapy. Irinotecan, a camptothecin analogue recently approved for used in conjunction with 5-fluorouricil/leucovorin, is a marginal improvement but toxic and by no means curative. Liposomal drug formulations are argued to be more …
-
Genomic heterogeneity in advanced colorectal cancer
Systemic chemotherapy is the primary treatment modality for metastatic colorectal carcinoma (MCRC). However, both conventional and novel chemotherapeutic drugs produce only modest improvements in outcome despite the introduction of predictive biomarkers. It is postulated that genomic heterogeneity …
-
Διακαθετηριακή θεραπεία μεταστατικού καρκίνου του ήπατος με σφαιρίδια που απελευθερώνουν χημειοθεραπευτικά
… colorectal cancer, who failed at least 1 line of systemic chemotherapy, were treated with chemoembolizations with microspheres (Hepasphere® MeritMedical ) preloaded with irinotecan. Beads were delivered selectively into hepatic segmental or lobar arteries. Response was evaluated following modified …
-
Διερεύνηση προγνωστικών παραγόντων και καρκινικών δεικτών στον καρκίνο του παγκρέατος
… patients into groups that might benefit from chemotherapy compared to best supportive care. In this retrospective study we analyzed the data from the history files of 215 patients from the oncology units of the participating hospitals. A series of 23 variables were analyzed statistically by …
-
Bacteria-Enabled Autonomous Drug Delivery Systems: Development, Characterization of Intratumoral Transport and Modeling
Systemic chemotherapy is a major therapeutic approach for nearly all types and stages of cancer. Success of this treatment depends not only on the efficacy of the therapeutics but also on the transport of the drug to all tumor cells in sufficient concentrations. Intratumoral drug transport is …
Page 1 of 4